| STOMACH CANCER - WITH DISTANT METASTASES OR INOPERABLE, UNRESECTABLE OR
                        RECURRENT | 
            
               
               | ALTERNATE NAMES  | Gastric Cancer; Gastric Carcinoma; Stomach Carcinoma | 
            
               
               | DESCRIPTION | Stomach Cancer forms in tissues lining the stomach. Age, diet, and stomach diseases can affect the
                     risk of developing stomach cancer. In the early stages, the following symptoms may
                     occur: indigestion and stomach discomfort, a bloated feeling after eating, mild nausea,
                     loss of appetite, and/or heartburn. In more advanced stages, the following symptoms
                     may occur: blood in the stool, vomiting, unintentional weight loss, stomach pain,
                     jaundice, and/or trouble swallowing.
                   | 
            
               
               | DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND ICD-9-CM/ICD-10-CM CODING  | Diagnostic testing: The following may be used to diagnose the disease: physical exam and history, blood
                     tests, endoscopy, fecal occult blood test (FOBT), barium swallow, biopsy, and/or CT
                     scan.
                   Physical findings: Most symptoms of gastric cancer reflect advanced disease. Patients may complain of
                     one or more of the following:
                   ICD-9: 151.9
                  ICD-10: C16.9 | 
            
               
               | PROGRESSION  | The progression of the disease depends on the stage and extent of the cancer, as well
                     as the patient's general health. Stomach cancer is often in an advanced stage when
                     diagnosed and is rarely cured.
                   | 
            
               
               | TREATMENT  | Treatment may include surgery, chemotherapy, radiation, or chemo-radiation. Treatment
                     of Stage IV Gastric Cancer may include palliative chemotherapy, endoluminal laser
                     therapy or endoluminal stent placement, palliative surgery, and/or a clinical trial
                     of new combinations of chemotherapy.
                   | 
            
               
               | SUGGESTED PROGRAMMATIC
                     ASSESSMENT* | 
            
               
               | Suggested MER for Evaluation: 
                     
                        
                           • 
                              A pathology report and an operative report are the preferred methods for documentation;
                        
                           • 
                              Clinical note from a surgeon that the cancer is inoperable or unresectable;
                        
                           • 
                              Surgical pathology report that the cancer was not completely removed and that the
                                 surgical margins were positive for malignancy; and
                              
                        
                           • 
                              In the absence of these reports, the adjudicator may use a physician's opinion that
                                 indicates the cancer is inoperable or unresectable based on described objective findings.
                               “Inoperable” refers to a physician's opinion that surgery would not be beneficial
                     based on a review of imaging studies, laboratory results, and physical examination
                     findings.
                   “Unresectable” cancer is established when the operative report indicates that the
                     cancer is not completely removed or the pathology report notes that the surgical specimen
                     has positive margins
                   | 
            
               
               | Suggested Listings for Evaluation: | 
            
               
               | DETERMINATION | LISTING | REMARKS | 
            
               
               | Meets | 13.16 B | Stomach Cancer that is inoperable, unresectable, recurrent, or with metastases meets
                     the criteria in 13.16 B.
                   | 
            
               
               | Equals |   |   | 
            
               
               | * Adjudicators may, at their discretion, use the Medical Evidence of Record or the
                     listings suggested to evaluate the claim. However, the decision to allow or deny the
                     claim rests with the adjudicator.
                   |